Single Gene Therapy Injection Restores Hearing in Deaf Patients

This gene therapy breakthrough tackles congenital deafness—previously considered incurable—by delivering a functional OTOF gene directly to the inner ear. With all ten trial patients showing hearing improvement and some achieving near-normal hearing within weeks, this treatment offers hope to millions with genetic hearing loss. The consistent safety profile and effectiveness across different age groups suggest a transformative approach to treating hereditary deafness.